| DC Field | Value | Language |
|---|
| dc.contributor.author | Alexei, Laura | |
| dc.date.accessioned | 2020-09-22T06:28:44Z | |
| dc.date.available | 2020-09-22T06:28:44Z | |
| dc.date.issued | 2020 | |
| dc.identifier.citation | ALEXEI, Laura. Caffeine and paracetamol. In: MedEspera: the 8th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2020, p. 283-284. | en_US |
| dc.identifier.uri | http://repository.usmf.md/handle/20.500.12710/11718 | |
| dc.identifier.uri | https://medespera.asr.md/wp-content/uploads/ABSTRACT-BOOK.pdf | |
| dc.description | Departament of Pharmacology and Clinical Pharmacology, Nicolae Testemitanu State
University of Medicine and Pharmacy, Chisinau, Republic of Moldova, The 8th International Medical Congress for Students and Young Doctors, September 24-26, 2020 | en_US |
| dc.description.abstract | Introduction. The diverse commercial names for paracetamol and combinations of this drug
are part of the OTC list and do not need a medical prescription. One of the compounds in these
combinations is caffeine, which is considered to enhance the effects of non-opioid analgesics
in symptomatic treatments or self-treatment of acute respiratory infections. Some patients use
these drugs due to the caffeine found in them without the awareness of other components and
their influence on the body. These circumstances could be responsible for acute intoxications
and fatal side-effects (such as fulminant hepatic necrosis). | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | MedEspera | en_US |
| dc.subject | paracetamol | en_US |
| dc.subject | caffeine | en_US |
| dc.subject | analgesia | en_US |
| dc.title | Caffeine and paracetamol | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | MedEspera 2020
|
